Mechelen, Belgium; January 5, 2026, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the works council consultation process regarding the wind-down of cell therapy activities has ...
Galapagos (GLPG) announced that the works council consultation process regarding the wind-down of cell therapy activities has been completed and ...
Galapagos' board of directors agreed to wind down the Belgian pharmaceutical company's cell therapies activities in a decision that will impact roughly 365 employees globally.